ストックスクリーナーアプリを入手
0.8301
8.28%
-0.0749
プレマーケット:
.83
-0.000100
-0.01%
Tela Bio Inc (TELA) 最新ニュース
TELA Bio Healthcare Story Faces New Market Scrutiny - Kalkine Media
TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25 - Yahoo Finance
About Us - FinancialContent
TELA Bio, Inc. (TELA) reports Q1 loss, beats revenue estimates - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA) - The Globe and Mail
Tela Bio Earnings Call Balances Momentum and Risk - TipRanks
TELA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Becton Hernia Mesh Antitrust Case Survives Dismissal - Law360
TELA Bio (NASDAQ: TELA) Q1 2026 revenue edges up as net loss widens - Stock Titan
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M - MSN
Q1 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio revenue up 3% to USD 19.1M in Q1 2026 - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2026 Earnings Call Transcript - Insider Monkey
TELA Bio, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong Eur - GuruFocus
TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript Summary - Moomoo
Is TELA Bio (TELA) a Possible Value Trap After Q1 2026? EPS Not - GuruFocus
TELA Bio Backs FY26 Revenue Guidance of at Least 8% Growth Over FY25 >TELA - Moomoo
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip By Investing.com - Investing.com South Africa
Tela Bio earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip - Investing.com Australia
TELA Bio Q1 2026 Earnings Call Transcript - Benzinga
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
TELA Bio posts modest Q1 growth, maintains 2026 outlook - TipRanks
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance - ChartMill
TELA Bio Reports First Quarter 2026 Financial Results - The Manila Times
TELA Bio Q1 revenue growth beats estimates, loss widens - TradingView
TELA Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TELA Bio, Inc. Provides Revenue Guidance for the Second Quarter 2026 and Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings - GuruFocus
TELA Q1'26 Earnings: EPS estimate is (0.18) USD - TradingView
TELA Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Why TELA Bio (TELA) could be the turning point you've been waiting for (Moonwalks) 2026-05-08Buy Signals - newser.com
TELA Bio (TELA) shares surge 11% after beating Q4 earnings estimates, defying analyst pessimism.Earnings Risk - newser.com
Earnings Preview: TELA Bio to Report Financial Results Post-market on May 12 - Moomoo
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Plans Board Overhaul, Reports Preliminary Q1 Revenue Beat - MyChesCo
TELA Bio (TELA) posts narrower than expected Q4 2025 loss, sending shares up 4.59 percent in today’s trading.Convertible Notes - newser.com
LIQUIFIX offers new approach to mesh fixation, TELA Bio claims - Traders Union
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), TELA Bio (TELA) and Nanobiotix (NBTX) - The Globe and Mail
TELA Bio Reshapes Board, Appoints New Chairman, Directors - The Globe and Mail
12 Health Care Stocks Moving In Friday's After-Market SessionAkanda (NASDAQ:AKAN), BioVie (NASDAQ:BIVI - Benzinga
What's Driving TELA Bio's Board Refreshment and Strategic Shift - Kavout
Lake Street Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Piper Sandler Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $1 - Moomoo
$19M Q1 tops TELA Bio outlook as 4 new directors join - Stock Titan
TELA Bio Taps Turnaround Titans for Board in Bold Push for Profitability - BriefGlance
TELA Stock Price, Quote & Chart | TELA BIO INC (NASDAQ:TELA) - ChartMill
Axos, Gallagher and TELA Bio post strong growth and strategic moves - MSN
TELA Bio: In Unanimous Decision by Current Seven-Member Bd of Directors, Four Directors Agreed to Step Dn Following Annual Meeting June 9 >TELA - Moomoo
1.72%
大文字化:
|
ボリューム (24 時間):